Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 36% ± 13% | |
lung | 16 studies | 35% ± 15% | |
intestine | 11 studies | 28% ± 14% | |
kidney | 7 studies | 25% ± 6% | |
brain | 7 studies | 27% ± 10% | |
liver | 6 studies | 31% ± 16% | |
eye | 5 studies | 24% ± 5% | |
lymph node | 5 studies | 31% ± 3% | |
bone marrow | 4 studies | 28% ± 7% | |
uterus | 4 studies | 36% ± 18% | |
breast | 4 studies | 30% ± 3% | |
pancreas | 3 studies | 45% ± 1% | |
placenta | 3 studies | 30% ± 7% | |
adrenal gland | 3 studies | 31% ± 9% | |
prostate | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5024.95 | 21 / 21 | 100% | 36.36 | 504 / 504 |
esophagus | 100% | 5436.33 | 1445 / 1445 | 100% | 26.97 | 183 / 183 |
intestine | 100% | 5087.53 | 966 / 966 | 100% | 41.96 | 527 / 527 |
kidney | 100% | 3983.27 | 89 / 89 | 100% | 21.25 | 901 / 901 |
lung | 100% | 4315.92 | 578 / 578 | 100% | 25.92 | 1155 / 1155 |
ovary | 100% | 5302.29 | 180 / 180 | 100% | 25.38 | 430 / 430 |
pancreas | 100% | 6936.40 | 328 / 328 | 100% | 25.31 | 178 / 178 |
prostate | 100% | 4904.54 | 245 / 245 | 100% | 31.30 | 502 / 502 |
skin | 100% | 6110.77 | 1809 / 1809 | 100% | 29.05 | 472 / 472 |
stomach | 100% | 5208.09 | 359 / 359 | 100% | 38.63 | 286 / 286 |
uterus | 100% | 4049.28 | 170 / 170 | 100% | 32.49 | 459 / 459 |
breast | 100% | 4345.73 | 459 / 459 | 100% | 26.10 | 1115 / 1118 |
thymus | 100% | 3803.94 | 653 / 653 | 100% | 21.87 | 603 / 605 |
liver | 100% | 2413.15 | 226 / 226 | 99% | 14.89 | 400 / 406 |
adrenal gland | 100% | 5946.38 | 258 / 258 | 98% | 16.97 | 225 / 230 |
brain | 98% | 2912.44 | 2595 / 2642 | 97% | 10.75 | 686 / 705 |
adipose | 100% | 4253.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4052.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 26.45 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.89 | 29 / 29 |
muscle | 100% | 3864.94 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4098.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.27 | 1 / 1 |
peripheral blood | 100% | 4735.28 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2431.75 | 838 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006362 | Biological process | transcription elongation by RNA polymerase I |
GO_0006383 | Biological process | transcription by RNA polymerase III |
GO_0005736 | Cellular component | RNA polymerase I complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005666 | Cellular component | RNA polymerase III complex |
GO_0003677 | Molecular function | DNA binding |
GO_0001056 | Molecular function | RNA polymerase III activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0001054 | Molecular function | RNA polymerase I activity |
GO_0005515 | Molecular function | protein binding |
Gene name | POLR1D |
Protein name | DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) (RNA polymerase I 16 kDa subunit) (RPA16) (RPC16) (hRPA19) POLR1D protein (RNA polymerase I and III subunit D) RNA polymerase I and III subunit D DNA-directed RNA polymerases I and III subunit RPAC2 (DNA-directed RNA polymerase I subunit D) HCG2020048, isoform CRA_c (RNA polymerase I and III subunit D) Protein POLR1D, isoform 2 |
Synonyms | hCG_2020048 |
Description | FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I and III which synthesize ribosomal RNA precursors and short non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs, respectively. . |
Accessions | ENST00000637071.1 ENST00000489647.4 ENST00000693488.1 ENST00000636952.2 ENST00000630983.1 A0A8I5KX40 A0A1B0GUZ5 A0A0R4J2F3 ENST00000692944.1 ENST00000685267.1 ENST00000399696.3 A0A087WTY1 A0A087X0U2 ENST00000637180.1 ENST00000302979.5 [P0DPB6-1] P0DPB6 Q7Z776 ENST00000636817.1 ENST00000465887.2 ENST00000621089.2 P0DPB5 A0A8I5QL02 ENST00000399697.7 [P0DPB5-1] |